SpyGlass Pharma SGP
NASDAQ SGP
$24.92 -1.58 (-5.96%)
At close: Oct 2, 2026 · 4:00 PM EDT

SpyGlass Pharma (SGP) Cash & Equivalents (2024 - 2026)

Updated

SpyGlass Pharma's Cash & Equivalents came in at $223.14 million for Q2 2026.

Analysis

SpyGlass Pharma (SGP) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, SpyGlass Pharma's Cash & Equivalents was $96.36 million, up 492.3% from FY2024.

  • Going back by year, Cash & Equivalents was $16.27 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 SpyGlass Pharma 886.33 Mn 886.33 Mn - 223.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 223.14 Mn
Dec 31, 2025 96.36 Mn
Dec 31, 2024 16.27 Mn
API Access

SpyGlass Pharma Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SGP&period=max&api_key=YOUR_API_KEY